Skip to content

Unilever to Weigh Raising Offer for Glaxo Consumer Unit

  • Dove owner could sell some Glaxo assets to buyout firms
  • Pharma giant rejected $68 billion offer, latest of three bids
Pfizer Products Ahead Of Earnings Release
Photographer: Daniel Acker/Bloomberg

Unilever Plc has held talks with banks about additional financing for a potential sweetened offer for GlaxoSmithKline Plc’s consumer products division, according to people familiar with the matter. 

Some financial firms have discussed lending enough for a bid higher than 50 billion pounds ($68 billion) -- the latest of three offers Glaxo has rejected for a bundle of brands including Advil painkiller and Sensodyne toothpaste.